These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34714458)

  • 1. The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.
    Obayashi K; Miki J; Fukuokaya W; Yanagisawa T; Kimura S; Tsuzuki S; Kimura T; Egawa S
    Int J Clin Oncol; 2022 Feb; 27(2):396-402. PubMed ID: 34714458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection.
    Zhou Q; Deng G; Wang Z; Dai G
    Front Surg; 2022; 9():1002075. PubMed ID: 36684178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment lung immune prognostic index as a biomarker in advanced non-small-cell lung cancer patients receiving first line pembrolizumab.
    Veccia A; Sforza V; Vattemi E; Inno A; Kinspergher S; Dipasquale M; Gori S; Morabito A; Baldi I; Caffo O
    Immunotherapy; 2021 Sep; 13(13):1093-1103. PubMed ID: 34190578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of dNLR and LIPI scores on the prognosis of elderly patients with non-surgical treatment of non-small cell lung cancer].
    Xie JH; Liu MM; Sun NN; Zhang L; Zhang HZ
    Zhonghua Zhong Liu Za Zhi; 2022 Sep; 44(9):975-980. PubMed ID: 36164700
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic significance of serum lactate dehydrogenase in patients undergoing radical cystectomy for bladder cancer.
    Su S; Liu L; Sun C; Yang L; Nie Y; Chen Y; Zhang J; Li S
    Urol Oncol; 2020 Nov; 38(11):852.e1-852.e9. PubMed ID: 32624424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer.
    Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M
    Thorac Cancer; 2020 Jun; 11(6):1578-1586. PubMed ID: 32286017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy.
    Li L; Pi C; Yan X; Lu J; Yang X; Wang C; Li X; Zhang S; Zhang Z; Sun Y; Hu Y
    Front Oncol; 2021; 11():697865. PubMed ID: 34692478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy.
    Araki T; Tateishi K; Komatsu M; Sonehara K; Kanda S; Hanaoka M; Koizumi T
    Thorac Cancer; 2022 Apr; 13(7):1006-1013. PubMed ID: 35156310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma.
    Feng JF; Zhao JM; Chen S; Chen QX
    Cancer Manag Res; 2021; 13():2811-2819. PubMed ID: 33814930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index.
    Ortega-Franco A; Hodgson C; Raja H; Carter M; Lindsay C; Hughes S; Cove-Smith L; Taylor P; Summers Y; Blackhall F; Califano R
    Target Oncol; 2022 Jul; 17(4):453-465. PubMed ID: 35781861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy.
    Herranz-Bayo E; Chara-Velarde LE; Cassinello-Espinosa J; Gimeno-Ballester V; Artal-Cortés Á; Moratiel-Pellitero A; Alcácera-López A; Navarro-Expósito F; Riesco-Montes B; Clemente-Andujar M
    Clin Transl Oncol; 2024 Sep; ():. PubMed ID: 39240302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancer.
    Zhang T; Xue W; Wang D; Xu K; Wu L; Wu Y; Zhou Z; Chen D; Feng Q; Liang J; Xiao Z; Hui Z; Lv J; Wang X; Deng L; Wang W; Liu W; Wang J; Zhai Y; Wang J; Bi N; Wang L
    Radiother Oncol; 2021 Mar; 156():244-250. PubMed ID: 33418003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
    Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
    Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Arıkan R; Alkış H; Işık S; Yaşar A; Çelebi A; Majidova N; Sever N; Adlı M; Demircan NC
    Cureus; 2023 Jun; 15(6):e40548. PubMed ID: 37465788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab.
    Nakamura K; Ishiyama Y; Nemoto Y; Ishihara H; Tachibana H; Fukuda H; Shinmura H; Hashimoto Y; Yoshida K; Iizuka J; Ishida H; Kondo T; Takagi T
    Int J Clin Oncol; 2023 Jul; 28(7):913-921. PubMed ID: 37103730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
    Kang M; Balpukov UJ; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2017 Jun; 15(3):e411-e420. PubMed ID: 28162942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS
    Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer.
    Wang W; Huang Z; Yu Z; Zhuang W; Zheng W; Cai Z; Shi L; Yu X; Lou G; Hong W; Zhang Y; Chen M; Song Z
    Front Oncol; 2020; 10():572853. PubMed ID: 33163403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
    Schuettfort VM; Gust K; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Enikeev D; Zimmermann K; Deuker M; Moschini M; Sari Motlagh R; Grossmann NC; Katayama S; Pradere B; Shariat SF
    Minerva Urol Nephrol; 2022 Jun; 74(3):302-312. PubMed ID: 34114784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Ann Surg Oncol; 2016 Jan; 23(1):335-42. PubMed ID: 26152275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.